Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis.

Cilfone, N A; Pienaar, E; Thurber, G M; Kirschner, D E; Linderman, J J

Cilfone, N A; Pienaar, E; Thurber, G M; Kirschner, D E; Linderman, J J.

Afiliación

Cilfone NA; Department of Chemical Engineering, University of Michigan Ann Arbor, Michigan, USA.
Pienaar E; Department of Chemical Engineering, University of Michigan Ann Arbor, Michigan, USA ; Department of Microbiology and Immunology, University of Michigan Medical School Ann Arbor, Michigan, USA.
Thurber GM; Department of Chemical Engineering, University of Michigan Ann Arbor, Michigan, USA.
Kirschner DE; Department of Microbiology and Immunology, University of Michigan Medical School Ann Arbor, Michigan, USA.
Linderman JJ; Department of Chemical Engineering, University of Michigan Ann Arbor, Michigan, USA.

CPT Pharmacometrics Syst Pharmacol ; 4(3): e00022, 2015 Mar.

Article en En | MEDLINE | ID: mdl-26225241

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google